John E. Harris, MD, PhD
Director, Vitiligo Clinic and Research Center
Chair Designate, Department of Dermatology
University of Massachusetts Medical School and UMass/Memorial Hospital
Worcester, MA USA
Advances in Immune Mechanisms of Vitiligo
Recent advances in understanding the immune mechanisms of vitiligo are leading to new treatments for the disease. Current strategies include inhibiting T cell function and migration to the skin, as well as long-term survival of autoreactive memory T cells. An advanced understanding of cellular signaling within vitiligo lesions may lead to more advanced therapeutic approaches in the future.